Francisco Esteban Selected Research

3,5-bis(trifluoromethyl)benzyl N-acetyltryptophan

4/2008

NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francisco Esteban Research Topics

Disease

6	Neoplasms (Cancer) 06/2015 - 11/2003
5	Carcinoma (Carcinomatosis) 09/2014 - 03/2004
4	Laryngeal Neoplasms (Laryngeal Cancer) 01/2011 - 02/2006
2	Inflammation (Inflammations) 12/2021 - 01/2009
2	Carcinogenesis 12/2021 - 03/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 12/2021
1	Thyroid Neoplasms (Thyroid Cancer) 04/2020
1	Sudden Hearing Loss (Sudden Deafness) 05/2012
1	Sensorineural Hearing Loss 05/2012
1	Squamous Cell Carcinoma of Head and Neck 06/2009
1	Infections 03/2007
1	Retropharyngeal Abscess 03/2007
1	Abscess 03/2007
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2006

Drug/Important Bio-Agent (IBA)

7	Substance PIBA 12/2021 - 04/2008
5	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 12/2021 - 04/2008
2	Monoclonal AntibodiesIBA 02/2006 - 03/2004
1	Piracetam (Nootropil)IBA 05/2012
1	SteroidsIBA 05/2012
1	AntioxidantsIBA 05/2012
1	AntigensIBA 01/2012
1	calpain 10IBA 01/2011
1	DAPIIBA 04/2008
1	3,5-bis(trifluoromethyl)benzyl N-acetyltryptophanIBA 04/2008
1	3- ((3,5- bis(trifluoromethyl)phenyl)methyloxy)- 2- phenylpiperidineIBA 04/2008
1	MitogensIBA 04/2008
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2007
1	Proteins (Proteins, Gene)FDA Link 01/2006
1	ClusterinIBA 01/2006
1	A-factor (Streptomyces)IBA 11/2003

Therapy/Procedure

1	Microelectrodes 09/2014
1	Therapeutics 05/2012
1	Punctures 03/2007